Literature DB >> 7931612

Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture.

C B Wilson1.   

Abstract

The author reviews the molecular genetics, pathology, and cell kinetics of meningiomas and the role that regional multiplicity in the dura mater may play in their recurrence. Malignant and radiation-induced meningiomas are discussed, with summaries of series of 60 patients with frankly malignant lesions treated over a period of 22 years at the University of California, San Francisco, and of 10 patients with meningiomas induced by high-dose radiation therapy. Reviewing a 23-year series of 140 patients with subtotally removed meningiomas who were treated post-operatively with radiation, the author recommends that, with meticulous technique, irradiation is effective in preventing the regrowth of subtotally removed benign meningiomas and of all malignant meningiomas. Adoption of both the microscopical cytological grading system proposed by Jääskeläinen's group in Helsinki and the classification of operations proposed by Donald Simpson is also recommended. Wide removal of dura adjacent to meningioma reduces the risk of recurrence, and determination of the bromodeoxyuridine labeling index provides a valid basis for planning treatment and follow-up evaluations. Increased awareness is necessary for early recognition of radiation-induced meningiomas in patients at risk for developing such tumors. For meningiomas in such sites as the parasellar region and the posterior fossa, conservative removal of tumor followed by irradiation is advocated in preference to a radical operation that may cause neurological injury without being curative.

Entities:  

Mesh:

Year:  1994        PMID: 7931612     DOI: 10.3171/jns.1994.81.5.0666

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  33 in total

Review 1.  Parasellar syndromes.

Authors:  Janine L Johnston
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

2.  Salvage chemotherapy with CPT-11 for recurrent meningioma.

Authors:  Marc C Chamberlain; Denice D Tsao-Wei; Susan Groshen
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

Review 3.  Radiation induced meningioma with a short latent period following high dose cranial irradiation - case report and literature review.

Authors:  Ajay Choudhary; Satyajit Pradhan; Mohammad Fakhrul Huda; Sureswar Mohanty; Mohan Kumar
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

4.  Prognostic significance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas.

Authors:  Y Kamei; M Watanabe; T Nakayama; K Kanamaru; S Waga; T Shiraishi
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

5.  Management of benign skull base meningiomas: a review.

Authors:  William M Mendenhall; William A Friedman; Robert J Amdur; Kelly D Foote
Journal:  Skull Base       Date:  2004-02

Review 6.  Management of pediatric intracranial meningiomas: an analysis of 31 cases and review of literature.

Authors:  Kapu Ravindranath; M C Vasudevan; Anil Pande; Nigel Symss
Journal:  Childs Nerv Syst       Date:  2013-01-05       Impact factor: 1.475

7.  Fractionated stereotactic radiotherapy for parasellar meningiomas: a preliminary report of visual outcomes.

Authors:  R S Behbehani; T McElveen; R C Sergott; D W Andrews; P J Savino
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

8.  Paediatric meningeal tumours.

Authors:  C L Mallucci; S E Parkes; P Barber; J Powell; M C Stevens; A R Walsh; A D Hockley
Journal:  Childs Nerv Syst       Date:  1996-10       Impact factor: 1.475

9.  High-dose radiation-induced meningiomas in elderly.

Authors:  M Salvati; L Cervoni; R Caruso; R Delfini; F M Gagliardi
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

10.  [The results of radiotherapy in meningiomas with a high risk of recurrence. A retrospective analysis].

Authors:  C Winkler; S Dornfeld; R Schwarz; S Friedrich; M Baumann
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.